Home > Financial Ratios > MANGALAM DRUGS AND ORGANICS

MANGALAM DRUGS AND ORGANICS
Core EBITDA Margin

    Back to All Ratios
MANGALAM DRUGS AND ORGANICS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MANGALAM DRUGS AND ORGANICS
Please provide your vote to see the results

MANGALAM DRUGS AND ORGANICS Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 4.726.9110.8815.087.57

What is the latest Core EBITDA Margin ratio of MANGALAM DRUGS AND ORGANICS ?

The latest Core EBITDA Margin ratio of MANGALAM DRUGS AND ORGANICS is 4.72 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar20244.72
Mar20236.91
Mar202210.88
Mar202115.08
Mar20207.57

How is Core EBITDA Margin of MANGALAM DRUGS AND ORGANICS Trending?

Years Core EBITDA Margin % Change
Mar2024 4.72
-31.69
Mar2023 6.91
-36.49
Mar2022 10.88
-27.85
Mar2021 15.08
99.21
Mar2020 7.57 -

Other Financial Ratios of MANGALAM DRUGS AND ORGANICS


Compare Core EBITDA Margin ratio of peers of MANGALAM DRUGS AND ORGANICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANGALAM DRUGS AND ORGANICS ₹179.0 Cr -1.4% 6.1% 15.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,684.0 Cr 2.9% 6.4% 48.1% Stock Analytics
DIVIS LABORATORIES ₹155,935.0 Cr 0.5% -2.1% 59.2% Stock Analytics
CIPLA ₹121,639.0 Cr 2.3% 1% 20.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,931.0 Cr 3.5% 15.7% 20.3% Stock Analytics
ZYDUS LIFESCIENCES ₹97,876.4 Cr -0.1% 2.3% 41.1% Stock Analytics


MANGALAM DRUGS AND ORGANICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANGALAM DRUGS AND ORGANICS

-1.4%

6.1%

15.1%

SENSEX

-0.7%

-1.6%

11.1%


You may also like the below Video Courses